Merrimack partnered with ZS to build a data and reporting infrastructure that enabled a brand-new commercial operation.
ASCO 2016 Lung Cancer Twitter Coverage
Lung cancer was a hot topic at ASCO 2016. Tweets about lung cancer increased 82% over 2015. The tweet with the highest engagement mentioned lung cancer as "...the most common cancer in the world." The promise of biomarkers intrigued ASCO attendees, with PD-L1 receiving the most attention.
Breast Cancer at ASCO 2016
Breast cancer was a big topic of discussion at ASCO 2016. The number of tweets about breast cancer increased 177% over 2015. MA-17R was the most discussed clinical trial. Trastuzumab dominated product mentions in the breast cancer space.
Key Social Media Trends at ASCO 2016
Social media continued to grow as a way for physicians to express their opinions about key trends in oncology. At this year’s ASCO conference, Twitter volume increased by 50% over 2015. Lung, breast, multiple myeloma, leukemia and lymphoma were the top tumor types discussed on Twitter.
Broken links: Why analytics investments have yet to pay off
This EIU study, "Broken links: Why analytics investments have yet to pay off," sponsored by ZS, draws on survey findings, interviews with senior corporate executives and desk research to explore the current state of sales and marketing analytics.
[e-Book] Business Model Transformation in Medtech
The healthcare industry has changed dramatically, and medtech firms are experimenting with new initiatives to evolve their business models. But many companies still have one foot in the past. Download this e-book to read ideas from ZS experts to help inform and guide you through this time of great change.
Three Analytics Priorities to Help Pharmaceutical Companies Break Through Healthcare’s Increasing Complexity
With the help of the Economist Intelligence Unit, ZS recently studied the performance of companies’ analytics capabilities across a range of industries and found that companies’ results have been underwhelming. Among 448 respondents, 70% rate sales and marketing analytics as “very” or “extremely” important to their competitive advantage, but just 2% report that they’ve managed to generate a “broad, positive impact” from their analytics investments thus far.
Displaying 1 - 15 of 439